OR WAIT null SECS
August 07, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, offers a brief overview of the Drug Supply Chain Security Act.
July 12, 2024
Why they are a game changer, and ways to a adapt to a new era of state privacy regulations.
June 11, 2024
With the standard constantly evolving across the pharma sector, the latest version can help bring benefits to the regulatory process.
June 06, 2024
If Congress doesn't act soon, it could result in more health inequities.
May 30, 2024
These advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.
May 21, 2024
In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry.
May 02, 2024
Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.
The partnership revolves around augmenting regulatory compliance, along with drug sampling distribution and compliance.
April 24, 2024
Citing a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly.
April 23, 2024
Approval comes amid positive results of a single-arm trial, showing a complete response rate of 77% in patients with Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer.